Alitretinoin (Toctino) for the indication preoperative treatment of severe chronic hand eczema

The applicant claims that treatment with alitretinoin is a cost-effective intervention for the treatment of severe chronic hand eczema. The CG concludes that the cost-effectiveness of alitretinoin in the treatment of severe chronic hand eczema has been validly estimated and that the cost-effectiveness is reasonable.

This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.